Skip to content

SCHEDULE 13GAccepted Apr 1, 5:29 PM ET

Vor Biopharma Inc. SCHEDULE 13G

TCG Crossover GP II, LLC

sec.gov(opens the filing on sec.gov)

Accepted (ET)

5:29 PM

Apr 1, 2026

Filed

Apr 1, 2026

Documents

2

Size

116.5 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.